Barinthus Biotherapeutics plc American (BRNS) Net Income by Year
Barinthus Biotherapeutics plc American reported a net loss of $66.4M in fiscal year 2025. This represents a decrease of 8.8% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Barinthus Biotherapeutics plc American has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BRNS Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
BRNS Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Barinthus Biotherapeutics plc American financials
Frequently Asked Questions
What was Barinthus Biotherapeutics plc American's net income in fiscal year 2025?
Barinthus Biotherapeutics plc American reported a net loss of $66.4M in fiscal year 2025.
How fast is Barinthus Biotherapeutics plc American's net income growing?
Barinthus Biotherapeutics plc American (BRNS) net income fell by 8.8% year over year, from -$61.1M to -$66.4M in fiscal year 2025.
How has Barinthus Biotherapeutics plc American's net income changed over the years?
Across the 6 fiscal years this page covers, Barinthus Biotherapeutics plc American (BRNS) net income went from -$17.7M in fiscal year 2020 to -$66.4M in fiscal year 2025.
What was Barinthus Biotherapeutics plc American's net income in the most recent quarter?
Barinthus Biotherapeutics plc American (BRNS) reported -$10.6M in net income in Q2 2026. This represents an increase of 49.9% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Barinthus Biotherapeutics plc American (BRNS) reported on that line in every period on record.